The pilot randomized controlled trial compared telemedicine-delivered CBT for insomnia in regular users of cannabis for sleep with sleep hygiene education for improving sleep and daytime functioning and reducing cannabis use.
The current study aimed to assess rates of response and remission with Lemborexant based on the Insomnia Severity Index in the insomnia short sleep subgroup.
Researchers sought to assess the epidemiology of comorbid sleep disorders in patients with migraine.
Researchers sought to compare the efficacy of a standard version of an internet-delivered CBT-I program, a culturally tailored version, and a sleep education control at improving insomnia symptoms.
A cognitive behavioral therapy (CBT) intervention for insomnia tailored for Black women improves sleep outcomes and intervention engagement.
For this analysis, data from the Irish arm of the COVID-19 Psychological Research Consortium (C19PRC) study were investigated.
In a retrospective, systematic review, researchers assessed the effectiveness and safety profile of Wuling for the treatment of insomnia.
In a systematic review and meta-analysis, researchers compared and evaluated the effect differences of multiple acupuncture therapies for patients with primary insomnia.
The researchers of this study explored the impact of a blended approach (bCBT) that included both face-to-face CBT and iCBT on patients with major depressive disorder and insomnia.
To better explore the effects of medical marijuana, investigators conducted a pragmatic, single-site, single-blind randomized controlled trial in the Greater Boston area between 2017 and 2020.
